MacroGenics
MGNX
#9265
Rank
NZ$0.17 B
Marketcap
NZ$2.74
Share price
0.63%
Change (1 day)
-52.16%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.17 Billion

As of December 2025 MacroGenics has a market cap of NZ$0.17 Billion. This makes MacroGenics the world's 9265th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.17 B-51.84%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Dec 23rd, 2025 the market cap of MacroGenics was reported to be:

NZ$0.17 Billion
by Nasdaq info icon info icon
NZ$0.17 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
NZ$1.88 B 991.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$241.93 B 139,664.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$448.72 B 259,121.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$265.67 B 153,373.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$305.29 B 176,260.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.643 T 949,059.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$188.98 B 109,075.66%๐Ÿ‡บ๐Ÿ‡ธ USA